Enhanced fluorescence imaging guided photodynamic therapy of sinoporphyrin sodium loaded graphene oxide

Biomaterials

Volumn 42, Issue , 2015, Pages 94-102

  Yan, Xuefeng ^a,b   Niu, Gang ^b   Lin, Jing ^b   Jin, Albert J ^b   Hu, Hao ^b   Tang, Yuxia ^b   Zhang, Yujie ^c   Wu, Aiguo ^c   Lu, Jie ^b   Zhang, Shaoliang ^d   Huang, Peng ^b   Shen, Baozhong ^a   Chen, Xiaoyuan ^b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

^c NINGBO INSTITUTE OF MATERIALS TECHNOLOGY AND ENGINEERING   (China)

^d Jiangxi Qinglong Group Co   (China)

Author keywords

Fluorescence imaging; Graphene oxide (GO); Photodynamic therapy; Photosensitizer; Sinoporphyrin sodium (DVDMS)

Indexed keywords

CHARGE TRANSFER; GRAPHENE; IMAGE ENHANCEMENT; PHOTODYNAMIC THERAPY; PHOTOSENSITIZERS; SODIUM COMPOUNDS; THERANOSTICS; TUMORS;

ENHANCED FLUORESCENCE IMAGING; FLUORESCENCE PROPERTIES; INTRA-MOLECULAR CHARGE TRANSFER; INTRAVENOUS INJECTIONS; PHOTODYNAMIC THERAPY (PDT); SINOPORPHYRIN SODIUM (DVDMS); THERANOSTIC AGENTS; TUMOR ACCUMULATION;

FLUORESCENCE IMAGING;

GRAPHENE OXIDE; PHOTOSENSITIZING AGENT; PORPHYRIN DERIVATIVE; SINGLET OXYGEN; SINOPORPHYRIN SODIUM; UNCLASSIFIED DRUG; GRAPHITE; MACROGOL DERIVATIVE; OXIDE; PORPHYRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DESIGN; FLUORESCENCE IMAGING; GLIOMA; GLIOMA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; ANIMAL; ATOMIC FORCE MICROSCOPY; CELL DEATH; CELL SURVIVAL; CHEMISTRY; DIAGNOSTIC IMAGING; DRUG EFFECTS; ENDOCYTOSIS; FLOW CYTOMETRY; INTRACELLULAR SPACE; METABOLISM; NUDE MOUSE; PHOTOCHEMOTHERAPY; SPECTROFLUOROMETRY; SYNTHESIS; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ANIMALS; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; DIAGNOSTIC IMAGING; ENDOCYTOSIS; FLOW CYTOMETRY; GRAPHITE; HUMANS; INTRACELLULAR SPACE; MICE, NUDE; MICROSCOPY, ATOMIC FORCE; OXIDES; PHOTOCHEMOTHERAPY; POLYETHYLENE GLYCOLS; PORPHYRINS; SINGLET OXYGEN; SPECTROMETRY, FLUORESCENCE; TISSUE DISTRIBUTION;

EID: 84919639263     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.11.040     Document Type: Article

References (48)

1. Lovell J.F., Liu T.W., Chen J., Zheng G. Activatable photosensitizers for imaging and therapy. Chem Rev 2010, 110:2839-2857.
2. Rai P., Mallidi S., Zheng X., Rahmanzadeh R., Mir Y., Elrington S., et al. Development and applications of photo-triggered theranostic agents. Adv Drug Deliv Rev 2010, 62:1094-1124.
3. Lovell J.F., Jin C.S., Huynh E., Jin H., Kim C., Rubinstein J.L., et al. Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. Nat Mater 2011, 10:324-332.
4. Huang P., Lin J., Wang X., Wang Z., Zhang C., He M., et al. Light-triggered theranostics based on photosensitizer-conjugated carbon dots for simultaneous enhanced-fluorescence imaging and photodynamic therapy. Adv Mater 2012, 24:5104-5110.
5. Celli J.P., Spring B.Q., Rizvi I., Evans C.L., Samkoe K.S., Verma S., et al. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem Rev 2010, 110:2795-2838.
6. Josefsen L.B., Boyle R.W. Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics. Theranostics 2012, 2:916-966.
7. Huang P., Lin J., Wang S., Zhou Z., Li Z., Wang Z., et al. Photosensitizer-conjugated silica-coated gold nanoclusters for fluorescence imaging-guided photodynamic therapy. Biomaterials 2013, 34:4643-4654.
8. Dougherty T.J., Gomer C.J., Henderson B.W., Jori G., Kessel D., Korbelik M., et al. Photodynamic therapy. JNatl Cancer Inst 1998, 90:889-905.
9. Chen J., Keltner L., Christophersen J., Zheng F., Krouse M., Singhal A., et al. New technology for deep light distribution in tissue for phototherapy. Cancer J 2002, 8:154-163.
10. Sun Y., Chen Z.L., Yang X.X., Huang P., Zhou X.P., Du X.X. Magnetic chitosan nanoparticles as a drug delivery system for targeting photodynamic therapy. Nanotechnology 2009, 20:135102.
11. Chen Z.L., Sun Y., Huang P., Yang X.X., Zhou X.P. Studies on preparation of photosensitizer loaded magnetic silica nanoparticles and their anti-tumor effects for targeting photodynamic therapy. Nanoscale Res Lett 2009, 4:400-408.
12. Bechet D., Couleaud P., Frochot C., Viriot M.-L., Guillemin F., Barberi-Heyob M. Nanoparticles as vehicles for delivery of photodynamic therapy agents. Trends Biotechnol 2008, 26:612-621.
13. Wang S., Gao R., Zhou F., Selke M. Nanomaterials and singlet oxygen photosensitizers: potential applications in photodynamic therapy. JMater Chem 2004, 14:487-493.
14. Lin J., Wang S., Huang P., Wang Z., Chen S., Niu G., et al. Photosensitizer-loaded gold vesicles with strong plasmonic coupling effect for imaging-guided photothermal/photodynamic therapy. ACS Nano 2013, 7:5320-5329.
15. Huang P., Li Z., Lin J., Yang D., Gao G., Xu C., et al. Photosensitizer-conjugated magnetic nanoparticles for invivo simultaneous magnetofluorescent imaging and targeting therapy. Biomaterials 2011, 32:3447-3458.
16. Huang P., Xu C., Lin J., Wang C., Wang X., Zhang C., et al. Folic acid-conjugated graphene oxide loaded with photosensitizers for targeting photodynamic therapy. Theranostics 2011, 1:240-250.
17. Wang S., Huang P., Nie L., Xing R., Liu D., Wang Z., et al. Single continuous wave laser induced photodynamic/plasmonic photothermal therapy using photosensitizer-functionalized gold nanostars. Adv Mater 2013, 25:3055-3061.
18. Zhu Z., Tang Z., Phillips J.A., Yang R., Wang H., Tan W. Regulation of singlet oxygen generation using single-walled carbon nanotubes. JAm Chem Soc 2008, 130:10856-10857.
19. Wang J., Zhu G., You M., Song E., Shukoor M.I., Zhang K., et al. Assembly of aptamer switch probes and photosensitizer on gold nanorods for targeted photothermal and photodynamic cancer therapy. ACS Nano 2012, 6:5070-5077.
20. Wang J., You M., Zhu G., Shukoor M.I., Chen Z., Zhao Z., et al. Photosensitizer-gold nanorod composite for targeted multimodal therapy. Small 2013, 9:3678-3684.
21. Liu J., Wang C., Jiang Y., Hu Y., Li J., Yang S., et al. Graphene signal amplification for sensitive and real-time fluorescence anisotropy detection of small molecules. Anal Chem 2013, 85:1424-1430.
22. Liu F., Zhou X., Chen Z., Huang P., Wang X., Zhou Y. Preparation of purpurin-18 loaded magnetic nanocarriers in cottonseed oil for photodynamic therapy. Mater Lett 2008, 62:2844-2847.
23. Tian B., Wang C., Zhang S., Feng L., Liu Z. Photothermally enhanced photodynamic therapy delivered by nano-graphene oxide. ACS Nano 2011, 5:7000-7009.
24. Rong P., Yang K., Srivastan A., Kiesewetter D.O., Yue X., Wang F., et al. Photosensitizer loaded nano-graphene for multimodality imaging guided tumor photodynamic therapy. Theranostics 2014, 4:229-239.
25. Jang B., Choi Y. Photosensitizer-conjugated gold nanorods for enzyme-activatable fluorescence imaging and photodynamic therapy. Theranostics 2012, 2:190-197.
26. Tang L., Chang H., Liu Y., Li J. Duplex DNA/graphene oxide biointerface: from fundamental understanding to specific enzymatic effects. Adv Funct Mater 2012, 22:3083-3088.
27. Wang K., Ruan J., Song H., Zhang J., Wo Y., Guo S., et al. Biocompatibility of graphene oxide. Nanoscale Res Lett 2011, 6:8.
28. Zhang J., Zhang F., Yang H., Huang X., Liu H., Zhang J., et al. Graphene oxide as a matrix for enzyme immobilization. Langmuir 2010, 26:6083-6085.
29. Zhang Y., Nayak T.R., Hong H., Cai W. Graphene: a versatile nanoplatform for biomedical applications. Nanoscale 2012, 4:3833-3842.
30. Shi S., Yang K., Hong H., Valdovinos H.F., Nayak T.R., Zhang Y., et al. Tumor vasculature targeting and imaging in living mice with reduced graphene oxide. Biomaterials 2013, 34:3002-3009.
31. Hong H., Yang K., Zhang Y., Engle J.W., Feng L., Yang Y., et al. Invivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene. ACS Nano 2012, 6:2361-2370.
32. Chung C., Kim Y.-K., Shin D., Ryoo S.-R., Hong B.H., Min D.-H. Biomedical applications of graphene and graphene oxide. Acc Chem Res 2013, 46:2211-2224.
33. Kim Y.-K., Na H.-K., Kwack S.-J., Ryoo S.-R., Lee Y., Hong S., et al. Synergistic effect of graphene oxide/MWCNT films in laser desorption/ionization mass spectrometry of small molecules and tissue imaging. ACS Nano 2011, 5:4550-4561.
34. Sun X., Liu Z., Welsher K., Robinson J.T., Goodwin A., Zaric S., et al. Nano-graphene oxide for cellular imaging and drug delivery. Nano Res 2008, 1:203-212.
35. Yang K., Zhang S., Zhang G., Sun X., Lee S.T., Liu Z. Graphene in mice: ultrahigh invivo tumor uptake and efficient photothermal therapy. Nano Lett 2010, 10:3318-3323.
36. Yang K., Feng L., Hong H., Cai W., Liu Z. Preparation and functionalization of graphene nanocomposites for biomedical applications. Nat Protoc 2013, 8:2392-2403.
37. Shen H., Zhang L., Liu M., Zhang Z. Biomedical applications of graphene. Theranostics 2012, 2:283-294.
38. Chang H., Tang L., Wang Y., Jiang J., Li J. Graphene fluorescence resonance energy transfer aptasensor for the thrombin detection. Anal Chem 2010, 82:2341-2346.
39. Jang H., Kim Y.K., Kwon H.M., Yeo W.S., Kim D.E., Min D.H. Agraphene-based platform for the assay of duplex-DNA unwinding by helicase. Angew Chem Int Ed Engl 2010, 122:5839-5843.
40. Geng J., Zhou L., Liu B. Graphene oxide enhanced fluorescence of conjugated polyelectrolytes with intramolecular charge transfer characteristics. Chem Commun (Camb) 2013, 49:4818-4820.
41. Zhou L., Wang W., Tang J., Zhou J.H., Jiang H.J., Shen J. Graphene oxide noncovalent photosensitizer and its anticancer activity invitro. Chem Eur J 2011, 17:12084-12091.
42. Zhou L., Jiang H., Wei S., Ge X., Zhou J., Shen J. High-efficiency loading of hypocrellin B on graphene oxide for photodynamic therapy. Carbon 2012, 50:5594-5604.
43. Hu J., Wang X., Zhang K., Wang P., Su X., Li Y., et al. Sinoporphyrin sodium: a novel sensitizer in sonodynamic therapy. Anticancer Drugs 2014, 25:174-182.
44. Wang H., Wang X., Zhang S., Wang P., Zhang K., Liu Q. Sinoporphyrin sodium, a novel sensitizer, triggers mitochondrial-dependent apoptosis in ECA-109 cells via production of reactive oxygen species. Int J Nanomed 2014, 9:3077-3090.
45. Hummers W.S., Offeman R.E. Preparation of graphitic oxide. JAm Chem Soc 1958, 80:1339.
46. Sun Z., Huang P., Tong G., Lin J., Jin A., Rong P., et al. VEGF-loaded graphene oxide as theranostics for multi-modality imaging-monitored targeting therapeutic angiogenesis of ischemic muscle. Nanoscale 2013, 5:6857-6866.
47. Lin H., Shen Y., Chen D., Lin L., Wilson B.C., Li B., et al. Feasibility study on quantitative measurements of singlet oxygen generation using singlet oxygen sensor green. JFluoresc 2013, 23:41-47.
48. Yang K., Wan J., Zhang S., Tian B., Zhang Y., Liu Z. The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power. Biomaterials 2012, 33:2206-2214.